Technical Analysis for BHC - Bausch Health Companies Inc.

Grade Last Price % Change Price Change
grade C 30.77 -4.50% -1.450
BHC closed down 4.5 percent on Wednesday, April 17, 2019, on 1.2 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: May 6

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical BHC trend table...

Date Alert Name Type % Chg
BB Squeeze Ended Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Resistance Bearish -4.50%
Bollinger Band Squeeze Range Contraction -4.50%
Stochastic Reached Oversold Weakness -4.50%

Older signals for BHC ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
S&P/Tsx 60 Index Medicine Biotechnology Laser Psoriasis Acne Actinic Keratosis
Is BHC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 36.52
52 Week Low 23.6
Average Volume 898,863
200-Day Moving Average 0.0
50-Day Moving Average 32.6942
20-Day Moving Average 33.229
10-Day Moving Average 33.436
Average True Range 1.0511
ADX 20.24
+DI 18.9715
-DI 30.496
Chandelier Exit (Long, 3 ATRs ) 32.4967
Chandelier Exit (Short, 3 ATRs ) 33.8533
Upper Bollinger Band 35.1812
Lower Bollinger Band 31.2768
Percent B (%b) -0.13
BandWidth 11.749977
MACD Line 0.0034
MACD Signal Line 0.3192
MACD Histogram -0.3158
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 33.395
Resistance 3 (R3) 33.663 33.057 32.958
Resistance 2 (R2) 33.057 32.388 32.923 32.812
Resistance 1 (R1) 31.913 31.975 31.610 31.645 32.666
Pivot Point 31.307 31.307 31.155 31.173 31.307
Support 1 (S1) 30.163 30.638 29.860 29.895 28.874
Support 2 (S2) 29.557 30.225 29.423 28.728
Support 3 (S3) 28.413 29.557 28.583
Support 4 (S4) 28.145